REYON Pharmaceutical Co., Ltd. (KRX:102460)

Market Cap	205.97B
Revenue (ttm)	148.04B
Net Income (ttm)	4.04B
Shares Out	18.34M
EPS (ttm)	220.05
PE Ratio	51.03
Forward PE	n/a
Dividend	150.00 (1.33%)
Ex-Dividend Date	n/a

Volume	12,000
Average Volume	21,281
Open	11,260
Previous Close	11,350
Day's Range	11,260 - 11,460
52-Week Range	9,830 - 18,650
Beta	0.74
RSI	39.12
Earnings Date	Aug 14, 2025

About REYON Pharmaceutical

REYON Pharmaceutical Co., Ltd. manufactures and sells medicines. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; antibiotics; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1955
• Employees: 448
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 102460

Financial Performance

In 2024, REYON Pharmaceutical's revenue was 148.30 billion, a decrease of -1.83% compared to the previous year's 151.07 billion. Earnings were 4.15 billion, an increase of 15.85%.